Trade Catalyst Pharmaceuticals - CPRX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.13 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 22.54 |
| Open | 22.96 |
| 1-Year Change | 58.13% |
| Day's Range | 22.29 - 22.96 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 22.87 | 0.00 | 0.00% | 22.87 | 23.04 | 22.25 |
| Jan 17, 2025 | 22.71 | 0.05 | 0.22% | 22.66 | 22.93 | 22.40 |
| Jan 16, 2025 | 22.59 | -0.19 | -0.83% | 22.78 | 23.15 | 22.05 |
| Jan 15, 2025 | 23.00 | 0.53 | 2.36% | 22.47 | 23.05 | 22.06 |
| Jan 14, 2025 | 22.13 | -0.04 | -0.18% | 22.17 | 22.83 | 21.78 |
| Jan 13, 2025 | 22.15 | 0.41 | 1.89% | 21.74 | 22.20 | 21.16 |
| Jan 10, 2025 | 21.86 | -0.91 | -4.00% | 22.77 | 22.77 | 21.29 |
| Jan 8, 2025 | 22.76 | 3.25 | 16.66% | 19.51 | 23.94 | 19.10 |
| Jan 7, 2025 | 19.46 | -0.60 | -2.99% | 20.06 | 20.06 | 19.37 |
| Jan 6, 2025 | 20.11 | -0.99 | -4.69% | 21.10 | 21.10 | 19.97 |
| Jan 3, 2025 | 21.23 | -0.24 | -1.12% | 21.47 | 21.48 | 21.19 |
| Jan 2, 2025 | 21.45 | 0.42 | 2.00% | 21.03 | 21.66 | 20.95 |
| Dec 31, 2024 | 20.83 | -0.20 | -0.95% | 21.03 | 21.17 | 20.76 |
| Dec 30, 2024 | 21.00 | -0.27 | -1.27% | 21.27 | 21.27 | 20.85 |
| Dec 27, 2024 | 21.39 | -0.34 | -1.56% | 21.73 | 21.84 | 21.20 |
| Dec 26, 2024 | 21.86 | 0.46 | 2.15% | 21.40 | 21.86 | 21.36 |
| Dec 24, 2024 | 21.52 | 0.04 | 0.19% | 21.48 | 21.57 | 21.28 |
| Dec 23, 2024 | 21.53 | 0.31 | 1.46% | 21.22 | 21.56 | 21.14 |
| Dec 20, 2024 | 21.20 | 0.03 | 0.14% | 21.17 | 21.31 | 20.95 |
| Dec 19, 2024 | 21.39 | -0.04 | -0.19% | 21.43 | 21.61 | 21.03 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Catalyst Pharmaceuticals Company profile
About Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company. The Company is focused on in-licensing, developing, and commercializing medicines for patients living with rare diseases. The Company is developing a pipeline of medicines for other rare diseases. The Company's product Firdapse Tablet, 10 mg, is used for the treatment of adults with Lambert-Eaton Myasthenic Syndrome (LEMS) patients (ages 17 and above) in the United States and Canada. Firdapse consists of the phosphate salt of amifampridine. It is developing a long-acting formulation of amifampridine phosphate. The Company's Firdapse is also developing clinical trials for the treatment of muscle-specific receptor tyrosine kinase-positive myasthenia gravis (MuSK-MG). Catalyst Pharmaceuticals Ireland, Ltd. is the subsidiary of the Company.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Catalyst Pharmaceuticals Inc revenues increased 18% to $140.8M. Net income decreased 47% to $39.5M. Revenues reflect Revenues increase of 16% to $138M. Net income was offset by Selling, general and adminis - Balancing increase of 14% to $45.2M (expense), reasear increase of 3% to $15.3M (expense), Other income, net decrease of 52% to $282K (income).
Equity composition
Common Stock $.001 Par, 4/11, 100M auth., 21,654,680 issd. Insiders own 22.54%. IPO 8/11/06, 3,350,000 shares @ $6 per share by First Albany Capital Inc. and Stifel, Nicolaus & Company, Incorporated. 9/08, P.O of 1.5M shares.
| Industry: | Biopharmaceuticals |
355 Alhambra Circle
Suite 801
CORAL GABLES
FLORIDA 33134
US
News
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com